An interventional study of Il-38 serum level in Bronchial Asthma, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 6 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-12.
Sponsored by Cairo University · Not applicable, Interventional, and Diagnostic
The aim of this study is to investigate the associations between serum IL-38 levels and different variables of asthma in children such as laboratory variables, pulmonary function test results, the diagnosis of asthma, and in correlation with disease severity.
3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.
This study's enrollment of 103 is above the median of 83 across 2,752 interventional studies indexed under Asthma.
Browse Asthma studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
patients diagnosed with bronchial asthma
Diagnostic Test: Il-38 serum level
healthy subjects with age and sex matched to bronchial asthma patients
Diagnostic Test: Il-38 serum level
measurement of serum levels of IL-38
serum IL-38 levels
Measurement of Interleukin 38 in sera of all study subjects by ELISA
Time frame: within 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University